Alkermes
ALKS
#2321
Rank
C$11.11 B
Marketcap
C$66.15
Share price
-1.43%
Change (1 day)
64.19%
Change (1 year)

EPS for Alkermes (ALKS)

EPS in 2026 (TTM): C-$0.002918

According to Alkermes's latest financial reports the company's current EPS (TTM) is C-$0.0000000000. In 2025 the company made an earnings per share (EPS) of C$2.11 a decrease over its 2024 EPS that were of C$3.19.

EPS history for Alkermes from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.002918-100.14%
2025C$2.11-34.08%
2024C$3.193.72%
2023C$3.08-323.96%
2022C-$1.38220%
2021C-$0.43-57.19%
2020C-$1.00-44.38%
2019C-$1.80
2017C-$1.48-24.82%
2016C-$1.96-9.87%
2015C-$2.18660%
2014C-$0.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57-12,033,301,387,828,041,728.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$7.52-9,457,550,908,645,464,064.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.02-1,279,021,170,502,529,280.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.84-3,567,802,533,542,780,416.00%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$6.47-8,142,500,972,776,666,112.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$10.20-12,826,240,470,391,562,240.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
C-$72.06 90,630,359,278,848,245,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.64-810,647,220,741,039,872.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel